Novolin

Product NDC
50090-0403
Requested package NDC
50090-0403-0
11-digit product format
500900403
Labeler code
50090
Product ID
50090-0403_6ffa1a5f-1a62-4017-999c-8ef13fa4f0c7
Type
HUMAN OTC DRUG
Nonproprietary name
Human Insulin
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Labeler
A-S Medication Solutions
Application
BLA019991
Marketing category
BLA
Marketing start
1991-06-25
Substance
INSULIN HUMAN
Active strength
100 [iU]/mL
Pharmacologic classes
Insulin [CS], Insulin [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 7 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2022-08-30 03:57 UTC · source 2022-08-29IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10IInactivated by FDA9bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05EExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…

Additional Listing Data#

Finished product
Yes
Brand name base
Novolin
Brand name suffix
70/30
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INSULIN HUMAN100 [iU]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1Y17CTI5SRInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
213442Internal RxNorm lookup
311048Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e825d7e9-467c-4f50-a6d6-f2602449c1deAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1997359-a049-4781-b04b-084a7f3cb039Product name220200325
aa12d3c0-d2b4-4c50-9af0-cb08b230ec20Product name220200323

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-0403-0Novolin70/3010 mL in 1 VIALINJECTION, SUSPENSION1014
50090-0403-0Novolin70/301 in 1 CARTONINJECTION, SUSPENSION114

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-0403-0ML - Milliliter50090-04032891ecaa-783b-4d88-8deb-63e4ab2595d012018-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-0403NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS]14Current NDC, Legacy NDC, 2 package rows20230801_e825d7e9-467c-4f50-a6d6-f2602449c1de.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Novolin 70/30HUMAN INSULINA-S Medication Solutionse825d7e9-467c-4f50-a6d6-f2602449c1de2023-02-06Warnings, Adverse reactionsExact identifier
application number: BLA019991
ndc (package): 50090-0403-0
ndc (product): 50090-0403
ndc11 (package): 50090040300
Novolin 70/30HUMAN INSULINNovo Nordisk508a2763-3cb7-4be5-9e53-544e84cd9b1f2022-11-23Warnings, Adverse reactionsExact identifier
application number: BLA019991

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
019991Novolin 70/30insulin isophane human and insulin human351(a)OTC2026-07-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311048insulin, human isophane / insulin regular 70/30 Injectable SuspensionPSNe825d7e9-467c-4f50-a6d6-f2602449c1de14
213442NovoLIN 70/30 Injectable SuspensionPSNe825d7e9-467c-4f50-a6d6-f2602449c1de14
213442insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable Suspension [Novolin]SBDe825d7e9-467c-4f50-a6d6-f2602449c1de14
311048insulin isophane, human 70 UNT/ML / insulin, regular, human 30 UNT/ML Injectable SuspensionSCDe825d7e9-467c-4f50-a6d6-f2602449c1de14
311048insulin, human mixed 70/30 100 UNT/ML Injectable SuspensionSYe825d7e9-467c-4f50-a6d6-f2602449c1de14
213442Novolin 70/30 Injectable SuspensionSYe825d7e9-467c-4f50-a6d6-f2602449c1de14
213442Relion Novolin 70/30 Injectable SuspensionSYe825d7e9-467c-4f50-a6d6-f2602449c1de14

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50090-0403-0500900403001 VIAL in 1 CARTON (50090-0403-0) / 10 mL in 1 VIAL1 vial2014-11-28NoNoCurrent